Delivery Order SPE2DB22D2206-SPE2DB23FJK68
Award Date 7/26/23
Potential Completion Date 7/27/23
Potential Value $3.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $826.12 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561419790 REPATHA 420 MG/3.5ML PUSHTRONX 3.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order period of performance is July 6-7, 2023. Under this delivery order, Amerisourcebergen will provide Repatha, a PCSK9 inhibitor medication used to reduce cholesterol, to the Defense Logistics Agency in support of its...
- The Defense Logistics Agency awarded a $1,316.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of REPATHA 140 MG/ML SURECLICKML. This order was placed under an existing Prime Vendor contract vehicle to provide pharmaceutical products and services to DOD medical treatment facilities. Amerisourcebergen will deliver the specified medication to a location in Conshohocken, Pennsylvania by September 26, 2023 to support DLA's mission of providing the military with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $1,041.42. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Troop Support Medical awarded a $4,039.80 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for REPATHA 140 MG/ML SURECLICKML. The order, which has no set-aside designation, is for the delivery of Repatha, a PCSK9 inhibitor for treatment of high cholesterol, to the place of performance in Conshohocken, Pennsylvania by the October 18, 2023 completion date. As the Defense Logistics Agency is responsible for...
- The Defense Logistics Agency awarded a $36,439.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors on November 5, 2025, with an ultimate completion date of November 6, 2025. This non-set-aside competitive award was issued as a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the agency. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,041.42 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of July 30, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running...
- The Defense Logistics Agency awarded a delivery order valued at $40,273.98 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. Repatha is a PCSK9 inhibitor used to treat high...
- The Defense Logistics Agency awarded a $22,095.24 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 5, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary pharmaceutical distribution operations....
- The Defense Logistics Agency awarded a $740.47 firm fixed price delivery order to Amerisourcebergen Drug Corporation for REPATHA 140 MG/ML SURECLICKML. The order is being fulfilled under the prime contractor's Corporate Office Division from its facility located in Conshohocken, Pennsylvania. The period of performance is August 14-15, 2023. No set aside designation or subcontractors are indicated. The Defense Logistics Agency supports America's armed forces by providing supplies in areas...
- The Defense Logistics Agency awarded a $27,145.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injectors on January 28, 2026, with a completion date of January 29, 2026. This is a non-set-aside competitive award, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems. The...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FJK68Delivery Order
The Defense Logistics Agency awarded a $3,269.73 firm fixed price delivery order to Amerisourcebergen Drug Corporation for REPATHA 140 MG/ML SURECLICKML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The contract period of performance spans July 26-27, 2023. This delivery order was issued under an existing DLA contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. Amerisourcebergen will deliver the specified quantity of Repatha, a PCSK9 inhibitor medication used to reduce LDL cholesterol, to the customer agency from its corporate distribution center. No subcontractors or set aside designations were indicated in the award information.
Generated 12/20/23, 3:36 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 7/26/23 |